----

| Minnesota                                                      |   | 41-1719250                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

| Title of class               |   | Name of Exchange on which registered |
|------------------------------|--------|--------------------------------------|
| Common Stock, $.01 par value |   | NASDAQ                               |

| Large Accelerated Filer o | Accelerated Filer x | Non-Accelerated Filer o | Smaller Reporting Company o |
|---------------------------|---------------------|-------------------------|-----------------------------|

----

----

----

| (a) | Documents filed as part of this Annual Report on Form 10-K: |
|-----|-------------------------------------------------------------|

|                                                     |   | PAGE    |
|----------------------------------------------------------|--------|---------|
| Reports of Independent Registered Public Accounting Firm |   | 39 - 40 |
| Consolidated Balance Sheets                              |   | 41      |
| Consolidated Statements of Operations                    |   | 43      |
| Consolidated Statements of Comprehensive Loss            |   | 44      |
| Consolidated Statements of Shareholders’ Equity    |   | 45      |
| Consolidated Statements of Cash Flows                    |   | 46      |
| Notes to Consolidated Financial Statements               |   | 47      |

|                                  |   | Balance at beginning of fiscal year |   |   | Additions charged to expenses |   |   | Written off, less recoveries |   |   | Effects of foreign currency fluctuations |   |   | Balance atend offiscal year |   |
|---------------------------------------|--------|-------------------------------------|--------|--------|-------------------------------|--------|--------|------------------------------|--------|--------|-----------------------------------------------|--------|--------|-----------------------------|--------|
| Allowance for doubtful accounts       |   |                                     |   |   |                               |   |   |                              |   |   |                                               |   |   |                             |   |
| Fiscal year ended March 31, 2013 |   | $                                   | 31,000 |   |                          | $      | 17,000 |                         |   | $      | (27,000                                       | )      |   | $                           | -      |   |   | $ | 21,000 |   |
| Fiscal year ended March 31, 2012 |   |                                | 11,000 |   |                          |   | 30,000 |                         |   |   | (9,000                                        | )      |   |                        | (1,000 | ) |   |   | 31,000 |   |
| Fiscal year ended March 31, 2011 |   |                                | 11,000 |   |                          |   | 5,000  |                         |   |   | (5,000                                        | )      |   |                        | -      |   |   |   | 11,000 |   |

|                                  |   | Balance at beginning of fiscal year |   |   | Additions charged againstrevenues |   |   | Returnswritten off |   |   | Effects of foreign currency fluctuations |   |   | Balance atend of fiscal year |   |
|---------------------------------------|--------|-------------------------------------|--------|--------|-----------------------------------|--------|--------|--------------------|--------|--------|------------------------------------------|--------|--------|------------------------------|--------|
| Allowance for sales returns           |   |                                     |   |   |                                   |   |   |                    |   |   |                                          |   |   |                              |   |
| Fiscal year ended March 31, 2013 |   | $                                   | 62,000 |   |                              | $      | 26,000 |               |   | $      | (35,000                                  | )      |   | $                            | -      |   |   | $ | 53,000 |   |
| Fiscal year ended March 31, 2012 |   |                                | 59,000 |   |                              |   | 82,000 |               |   |   | (79,000                                  | )      |   |                         | -      |   |   |   | 62,000 |   |
| Fiscal year ended March 31, 2011 |   |                                | 61,000 |   |                              |   | 29,000 |               |   |   | (31,000                                  | )      |   |                         | -      |   |   |   | 59,000 |   |

----

|  | Number | Description |
|--|--------|-------------|

|  |   3.1 | Amended & Restated By Laws of Uroplasty, Inc. (Incorporated by reference to Exhibit 3.1 to Registrant’s Form 8-K filed November 20, 2009) |
|--|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|

|  |   3.2 | Restated Articles of Incorporation of Uroplasty, Inc. (Incorporated by reference to Exhibit 3.1 to Registrant’s Registration Statement on Form SB-2 filed October 18, 2007 (File No. 333-146787)) |
|--|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.1 | Settlement Agreement and Release dated November 30, 1993 by and between Bioplasty, Inc., Bio-Manufacturing, Inc., Uroplasty, Inc., Arthur A. Beisang, Arthur A. Beisang III, MD and Robert A. Ersek, MD (Incorporated by reference to Exhibit 6.1 to Registrant’s Registration Statement on Form 10SB filed July 10, 1996) |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.2* | Employment Agreement between Uroplasty, Inc. and Susan Holman dated December 7, 1999. (Incorporated by reference to Exhibit 10.13 to Registrant’s Form 10-KSB for the year ended March 31, 2000 filed June 26, 2000) |
|--|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.3* | Employment Agreement between Uroplasty, Inc. and Larry Heinemann dated December 7, 1999. (Incorporated by reference to Exhibit 10.14 to Registrant’s Form 10-KSB for the year ended March 31, 2000, filed June 26, 2000) |
|--|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.4 | Agreement, dated October 14, 1998, by and between Uroplasty, Inc. and Samir M. Henalla (pertaining to Macroplastique Implantation System). (Incorporated by reference to Exhibit 10.15 to Registrant’s Form 10-KSB/A for the year ended March 31, 2001, filed March 27, 2002) |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.5* | 2002 Employee Stock Option Plan (Incorporated by reference to the copy filed as Appendix B to the Proxy Statement filed with the SEC on August 1, 2002) |
|--|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.6* | Employment Agreement between Uroplasty, Inc. and Mr. Marc Herregraven dated November 15, 2002. (Incorporated by reference to Exhibit 10.15 to Registrant’s Form 10-KSB for the year ended March 31, 2003, filed May 20, 2003) |
|--|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.7* | Employment Agreement between Uroplasty, Inc. and Mahedi A. Jiwani dated November 14, 2005 (Incorporated by reference to Exhibit 10.24 to Registrant’s Form 10-QSB filed November 14, 2005) |
|--|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.8* | Employment Agreement between Uroplasty, Inc. and David B. Kaysen dated May 17, 2006 (Incorporated by reference to Exhibit 10.30 to Registrant’s Form 10-KSB filed June 29, 2006) |
|--|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.9* | 2006 Amended Stock and Incentive Plan (Incorporated by reference to the copy attached as Appendix A to the Company’s Definitive Proxy Statement filed on July 25, 2008) |
|--|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.10* | Amendment to the Employment Agreement between Uroplasty, Inc. and Mr. David B. Kaysen. (Incorporated by reference to Exhibit 10.1 to Registrant’s Form 8-K dated April 26, 2011) |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.11 | Lease Agreement between Uroplasty, Inc. and Liberty Property Limited Partnership dated January 20, 2006 (Incorporated by reference to Exhibit 10.25 to Registrant’s Form 8-K filed January 24, 2006) |
|--|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.12 | Form of Purchase Agreement, dated as of March 15, 2007, by and between Uroplasty, Inc. and CystoMedix, Inc. (Incorporated by reference to Exhibit 10.36 to Registrant’s Form 8-K filed March 20, 2007 |
|--|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.13* | Employment Agreement between Uroplasty, Inc. and Nancy Kolb dated May 22, 2012 (Incorporated by reference to Exhibit 10.13 to Registrant’s Form 10-K filed May 24, 2012) |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 10.14*# | Employment Agreement between Uroplasty, Inc. and Darin Hammers dated February 11, 2013 |
|--|---------|----------------------------------------------------------------------------------------|

|  | 10.15*# | Employment Agreement between Uroplasty, Inc. and Robert C. Kill dated July 22, 2013 |
|--|---------|-------------------------------------------------------------------------------------|

|  | 10.16*# | Amended and Restated Separation Agreement July 22, 2013, between Uroplasty, Inc. and David B. Kaysen |
|--|---------|------------------------------------------------------------------------------------------------------|

|  | 10.17*# | Separation Agreement dated July 19, 2013 between Uroplasty and Mahedi Jiwani |
|--|---------|------------------------------------------------------------------------------|

----

|  | 14.1 | Revised Code of Ethics titled Code of Business Conduct and Ethics for Directors, Officers and Employees (Incorporated by reference to Exhibit 14.1 to Registrant’s Form 8-K filed April 12, 2007) |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 21.0# | List of Subsidiaries |
|--|-------|----------------------|

|  | 24.1# | Power of Attorney |
|--|-------|-------------------|

|  | 23.1# | Consent of Independent Registered Public Accounting Firm – Grant Thornton LLP |
|--|-------|-------------------------------------------------------------------------------------|

|  | 31# | Certification by the CEO and CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|--|-----|--------------------------------------------------------------------------------------------|

|  | 32# | Certification by the CEO and CFO pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------|

|  | 101# | Financial statements from the Annual Report on Form 10-K for the year ended March 31, 2013, formatted in Extensible Business Reporting Language: (i) Financial Statement Schedules, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Operations, (iv) the Consolidated Statements of Shareholders’ Equity and Comprehensive Loss, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | Number | Description |
|--|--------|-------------|

|  | 99.1 | Press Release dated July 23, 2013. |
|--|------|------------------------------------|

----

| Dated: July 23, 2013 | UROPLASTY, INC.                       |
|----------------------|---------------------------------------|
|                 |                                  |   |
|                 | By                                    |    /s/ Robert C. Kill |
|                 | Robert C. Kill                        |
|                 | President and Chief Executive Officer |

| Name                                                                                                                                                                                                                                                                                                                                                   |  | Title / Capacity                                                                            |  | Date          |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|---------------------------------------------------------------------------------------------|--|---------------|
|                                                                                                                                                                                                                                                                                                                                                   |  |                                                                                        |  |          |
| /s/ Robert C. Kill                                                       |  | Chief Executive Officer, Acting Chief                                                       |  | July 23, 2013 |
| Robert C. Kill                                                                                                                                                                                                                                                                                                                                         |  | Financial Officer and Director                                                              |  |               |
|                                                                                                                                                                                                                                                                                                                                                   |  | (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |  |               |
|                                                                                                                                                                                                                                                                                                                                                        |  |                                                                                             |  |               |
| /s/ R. Patrick Maxwell*                                                                                                                                                                                                                                                                                                                      |  | Director                                                                                    |  | July 23, 2013 |
| R. Patrick Maxwell                                                                                                                                                                                                                                                                                                                                     |  |                                                                                             |  |               |
|                                                                                                                                                                                                                                                                                                                                                   |  |                                                                                             |  |               |
| /s/ Thomas E. Jamison*                                                                                                                                                                                                                                                                                                                       |  | Director                                                                                    |  | July 23, 2013 |
| Thomas E. Jamison                                                                                                                                                                                                                                                                                                                                      |  |                                                                                        |  |               |
|                                                                                                                                                                                                                                                                                                                                                   |  |                                                                                             |  |               |
| /s/ Lee A. Jones*                                                        |  | Director                                                                                    |  | July 23, 2013 |
| Lee A. Jones                                                                                                                                                                                                                                                                                                                                           |  |                                                                                        |  |               |
|                                                                                                                                                                                                                                                                                                                                                   |  |                                                                                        |  |          |
| /s/ James P. Stauner*                                                                                                                                                                                                                                                                                                                        |  | Chairman of the Board of Directors                                                          |  | July 23, 2013 |
| James P. Stauner                                                                                                                                                                                                                                                                                                                                       |  |                                                                                        |  |          |
|                                                                                                                                                                                                                                                                                                                                                   |  |                                                                                             |  |               |
| /s/ Sven A. Wehrwein*                                                                                                                                                                                                                                                                                                                        |  | Director                                                                                    |  | July 23, 2013 |
| Sven A. Wehrwein                                                                                                                                                                                                                                                                                                                                       |  |                                                                                        |  |               |

----

----